Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mimicry of host short linear motif-mediated interactions utilised by viruses for entry. | Mol Biol Rep | 2023 | 37016039 | PubTator, text mining | PubMed |
| T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis. | Front Immunol | 2023 | 36993982 | PubTator, text mining | PubMed |
| Spleen regeneration after subcutaneous heterotopic autotransplantation in a mouse model. | Biol Res | 2023 | 36991509 | PubTator, text mining | PubMed |
| Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study. | Pharmaceutics | 2023 | 36986833 | PubTator, text mining | PubMed |
| Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases. | Pharmaceutics | 2023 | 36986830 | PubTator, text mining | PubMed |
| What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. | Metabolites | 2023 | 36984818 | PubTator, text mining | PubMed |
| Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders. | Int J Mol Sci | 2023 | 36982892 | PubTator, text mining | PubMed |
| Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment. | Int J Mol Sci | 2023 | 36982789 | PubTator, text mining | PubMed |
| Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases. | Int J Mol Sci | 2023 | 36982601 | PubTator, text mining | PubMed |
| Pivotal Role of Intestinal Microbiota and Intraluminal Metabolites for the Maintenance of Gut-Bone Physiology. | Int J Mol Sci | 2023 | 36982235 | PubTator, text mining | PubMed |
| Design and Pharmacological Characterization of α4β1 Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism. | J Med Chem | 2023 | 36976921 | PubTator, text mining | PubMed |
| Salmonella infection induces the reorganization of follicular dendritic cell networks concomitant with the failure to generate germinal centers. | iScience | 2023 | 36950118 | PubTator, text mining | PubMed |
| The Underappreciated Role of Secretory IgA in IBD. | Inflamm Bowel Dis | 2023 | 36943800 | PubTator, text mining | PubMed |
| IgA-producing B cells in lung homeostasis and disease. | Front Immunol | 2023 | 36936934 | PubTator, text mining | PubMed |
| A Single-Center Study of Long-Term Effectiveness of Vedolizumab in Anti-TNF Refractory Pediatric Inflammatory Bowel Disease. | JPGN Rep | 2023 | 36915867 | PubTator, text mining | PubMed |
| MAdCAM-1 costimulation in the presence of retinoic acid and TGF-β promotes HIV infection and differentiation of CD4+ T cells into CCR5+ TRM-like cells. | PLoS Pathog | 2023 | 36897929 | PubTator, text mining | PubMed |
| Aldh1a2 + fibroblastic reticular cells regulate lymphocyte recruitment in omental milky spots. | J Exp Med | 2023 | 36880532 | PubTator, text mining | PubMed |
| Lymphoid stromal cells - potential implications for the pathogenesis of CVID. | Front Immunol | 2023 | 36875120 | PubTator, text mining | PubMed |
| The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis. | Front Cell Neurosci | 2023 | 36874213 | PubTator, text mining | PubMed |
| Cost effective and reliable cell based ELISA as an alternative method of flow cytometry for assessment of binding activity of Vedolizumab. | Heliyon | 2023 | 36865445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=12